APExBIO - Cyclosporin A|Immunosuppressive agent|CAS# 59865-13-3
MedChemExpress on Twitter: "#Cyclosporin A is an #immunosuppressant that binds to the #cyclophilin and inhibits #phosphatase activity of #calcineurin with an IC50 of 5 nM. Cyclosporin A also inhibits #CD11a/#CD18 adhesion. #drugdiscovery.
Cyclosporin A, >99% | LC Laboratories
Cyclosporin A ReadyMade™ Solution-Coronavirus research-TOKU-E
Cyclosporin A - BML-A195 - Enzo Life Sciences
Dihydro Cyclosporin A | TRC-D448865-10MG | LGC Standards
Cyclosporin A |Cyclosporine; Antibiotic S 7481F1; Ciclosporin A; CSA; cyclosporine A | Calcineurin inhibitor | Hello Bio
59865-13-3 | Cyclosporin A | 株式会社島津ジーエルシー
Cyclosporin A, What is Cyclosporin A? About its Science, Chemistry and Structure
Medchemexpress LLC HY-B0579 500mg , Cyclosporin A Cyclosporine;Ciclosporin | Fisher Scientific
Ciclosporin - Wikipedia
Cyclosporin A (Cyclosporine A) | Calcineurin Inhibitor | MedChemExpress
Cyclosporin A-d4 (Major) | Cyclosporine-d4; Ciclosporin-d4; Atopica-d4; Sandimmun(e)-d4; Neoral-d4; Optimmune-d4; | C₆₂H₁₀₇D₄N₁₁O₁₂ | TRC
Cyclosporin A-d4 (Cyclosporine A-d4) | Stable Isotope | MedChemExpress
--thuoc.jpg "Ciclosporin (Cyclosporin A) - Thuốc chống thấp khớp tác dụng chậm - Y Học Cộng Đồng")
Ciclosporin (Cyclosporin A) - Thuốc chống thấp khớp tác dụng chậm - Y Học Cộng Đồng
Frontiers | Lessons to Learn From Low-Dose Cyclosporin-A: A New Approach for Unexpected Clinical Applications
Measure particle size distribution of Cyclosporin A with Nanoptic 90 Plus
FC20749 | 59865-13-3 | Cyclosporin A | Biosynth
Role of (pro)renin receptor in cyclosporin A-induced nephropathy | American Journal of Physiology-Renal Physiology
Cyclosporin A | 59865-13-3
Cyclosporine a | Sigma-Aldrich
Cyclosporin A | Cell Signaling Technology
Structural characteristics of cyclosporine A. Cyclosporin A is an 11... | Download Scientific Diagram
A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer | Signal Transduction and Targeted Therapy
